238 related articles for article (PubMed ID: 27623776)
21. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
[TBL] [Abstract][Full Text] [Related]
22. Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol.
Seo K; Yamamoto Y; Kirillova A; Kawana M; Yadav S; Huang Y; Wang Q; Lane KV; Pruitt BL; Perez MV; Bernstein D; Wu JC; Wheeler MT; Parikh VN; Ashley EA
Circulation; 2023 Nov; 148(21):1691-1704. PubMed ID: 37850394
[TBL] [Abstract][Full Text] [Related]
23. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.
Liu N; Ruan Y; Denegri M; Bachetti T; Li Y; Colombi B; Napolitano C; Coetzee WA; Priori SG
J Mol Cell Cardiol; 2011 Jan; 50(1):214-22. PubMed ID: 20937285
[TBL] [Abstract][Full Text] [Related]
24. Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation.
Sung RJ; Lo CP; Hsiao PY; Tien HC
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1625-38. PubMed ID: 21742998
[TBL] [Abstract][Full Text] [Related]
25. The ryanodine receptor store-sensing gate controls Ca2+ waves and Ca2+-triggered arrhythmias.
Chen W; Wang R; Chen B; Zhong X; Kong H; Bai Y; Zhou Q; Xie C; Zhang J; Guo A; Tian X; Jones PP; O'Mara ML; Liu Y; Mi T; Zhang L; Bolstad J; Semeniuk L; Cheng H; Zhang J; Chen J; Tieleman DP; Gillis AM; Duff HJ; Fill M; Song LS; Chen SR
Nat Med; 2014 Feb; 20(2):184-92. PubMed ID: 24441828
[TBL] [Abstract][Full Text] [Related]
26. FKBPs facilitate the termination of spontaneous Ca2+ release in wild-type RyR2 but not CPVT mutant RyR2.
Zhang JZ; Waddell HM; Wu E; Dholakia J; Okolo CA; McLay JC; Jones PP
Biochem J; 2016 Jul; 473(14):2049-60. PubMed ID: 27154203
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.
Jiang D; Jones PP; Davis DR; Gow R; Green MS; Birnie DH; Chen SR; Gollob MH
Channels (Austin); 2010; 4(4):302-10. PubMed ID: 20676041
[TBL] [Abstract][Full Text] [Related]
28. Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release.
Søndergaard MT; Tian X; Liu Y; Wang R; Chazin WJ; Chen SR; Overgaard MT
J Biol Chem; 2015 Oct; 290(43):26151-62. PubMed ID: 26309258
[TBL] [Abstract][Full Text] [Related]
29. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
Fernández-Velasco M; Rueda A; Rizzi N; Benitah JP; Colombi B; Napolitano C; Priori SG; Richard S; Gómez AM
Circ Res; 2009 Jan; 104(2):201-9, 12p following 209. PubMed ID: 19096022
[TBL] [Abstract][Full Text] [Related]
30. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279
[TBL] [Abstract][Full Text] [Related]
31. S4153R is a gain-of-function mutation in the cardiac Ca(2+) release channel ryanodine receptor associated with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.
Zhabyeyev P; Hiess F; Wang R; Liu Y; Wayne Chen SR; Oudit GY
Can J Cardiol; 2013 Aug; 29(8):993-6. PubMed ID: 23498838
[TBL] [Abstract][Full Text] [Related]
32. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.
Liu N; Colombi B; Memmi M; Zissimopoulos S; Rizzi N; Negri S; Imbriani M; Napolitano C; Lai FA; Priori SG
Circ Res; 2006 Aug; 99(3):292-8. PubMed ID: 16825580
[TBL] [Abstract][Full Text] [Related]
33. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
[TBL] [Abstract][Full Text] [Related]
34. The arrhythmogenic human HRC point mutation S96A leads to spontaneous Ca(2+) release due to an impaired ability to buffer store Ca(2+).
Zhang JZ; McLay JC; Jones PP
J Mol Cell Cardiol; 2014 Sep; 74():22-31. PubMed ID: 24805197
[TBL] [Abstract][Full Text] [Related]
35. Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor: sensitization of store overload-induced Ca2+ release.
Xiao B; Tian X; Xie W; Jones PP; Cai S; Wang X; Jiang D; Kong H; Zhang L; Chen K; Walsh MP; Cheng H; Chen SR
J Biol Chem; 2007 Oct; 282(41):30256-64. PubMed ID: 17693412
[TBL] [Abstract][Full Text] [Related]
36. Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death.
Jiang D; Chen W; Wang R; Zhang L; Chen SR
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18309-14. PubMed ID: 17984046
[TBL] [Abstract][Full Text] [Related]
37. Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy.
Kang G; Giovannone SF; Liu N; Liu FY; Zhang J; Priori SG; Fishman GI
Circ Res; 2010 Aug; 107(4):512-9. PubMed ID: 20595652
[TBL] [Abstract][Full Text] [Related]
38. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
[TBL] [Abstract][Full Text] [Related]
39. Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.
Kong H; Wang R; Chen W; Zhang L; Chen K; Shimoni Y; Duff HJ; Chen SR
Biophys J; 2007 Apr; 92(8):2757-70. PubMed ID: 17259277
[TBL] [Abstract][Full Text] [Related]
40. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.
Hilliard FA; Steele DS; Laver D; Yang Z; Le Marchand SJ; Chopra N; Piston DW; Huke S; Knollmann BC
J Mol Cell Cardiol; 2010 Feb; 48(2):293-301. PubMed ID: 19835880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
